NCT06176443Completed
Impact of an Increased Restrictive Factor of One Anastomosis Gastric Bypass on Metabolic Outcomes Type 2 Diabetes.
Impact of an Increased Restrictive Factor of One Anastomosis Gastric Bypass Using a "FundoRing" Fundoplication on Metabolic Outcomes in Type 2 Diabetes Mellitus: a Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 21 Nov 2024
Brief summary (registry, in English)
The purpose of the study is to evaluate the effect of an increased restrictive factor of one gastric anastomosis (OAGB) using a "FundoRing" fundoplication on metabolic outcomes in type 2 diabetes mellitus. The randomized controlled trial compared two interventional procedures: one group - using the original fundoplication procedure to enhance the restrictive effect and another group without fundoplication in the standard version of the OAGB.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 300 (actual)
- First submitted
- 9 Dec 2023
- Start date
- 13 Jan 2020
- Primary completion date
- 13 Jan 2024
- Lead sponsor
- The Society of Bariatric and Metabolic Surgeons of Kazakhstan
- Diseases
- Obesity, Type 1 diabetes, Type 2 diabetes
- NCT number
- NCT06176443
What you commit to
- Study type: Interventional
- Participants enrolled: 300
- From 13 Jan 2020 to the primary completion date, 13 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients without Diabetes Mellitus, Type 2
- History of surgery on the stomach
- Psychiatric illness
Age
- Less than 18 or more than 60 years of age
Other
- BMI \<25 and \>55 kg/m2
- Patients unwilling or unable to provide informed consent
Who the study is looking for
- BMI 25-55 kg/m2
- Patients with Diabetes Mellitus, Type 2
Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Oral Ospanov Coordinator of this site? Confirm its status | Astana | Kazakhstan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.